Intuitive Surgical Debt to Equity Ratio 2010-2025 | ISRG
Current and historical debt to equity ratio values for Intuitive Surgical (ISRG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Intuitive Surgical debt/equity for the three months ending March 31, 2025 was 0.00.
| Intuitive Surgical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $2.01B | $17.21B | 0.12 |
| 2024-12-31 | $2.21B | $16.53B | 0.13 |
| 2024-09-30 | $2.07B | $15.68B | 0.13 |
| 2024-06-30 | $1.85B | $14.80B | 0.13 |
| 2024-03-31 | $1.78B | $14.05B | 0.13 |
| 2023-12-31 | $2.04B | $13.40B | 0.15 |
| 2023-09-30 | $2.09B | $12.62B | 0.17 |
| 2023-06-30 | $1.94B | $11.96B | 0.16 |
| 2023-03-31 | $1.76B | $11.29B | 0.16 |
| 2022-12-31 | $1.86B | $11.11B | 0.17 |
| 2022-09-30 | $1.69B | $11.57B | 0.15 |
| 2022-06-30 | $1.62B | $12.08B | 0.13 |
| 2022-03-31 | $1.52B | $12.16B | 0.13 |
| 2021-12-31 | $1.60B | $11.95B | 0.13 |
| 2021-09-30 | $1.48B | $11.46B | 0.13 |
| 2021-06-30 | $1.42B | $10.88B | 0.13 |
| 2021-03-31 | $1.35B | $10.19B | 0.13 |
| 2020-12-31 | $1.41B | $9.76B | 0.14 |
| 2020-09-30 | $1.33B | $9.29B | 0.14 |
| 2020-06-30 | $1.34B | $8.77B | 0.15 |
| 2020-03-31 | $1.36B | $8.53B | 0.16 |
| 2019-12-31 | $1.45B | $8.29B | 0.18 |
| 2019-09-30 | $1.35B | $7.78B | 0.17 |
| 2019-06-30 | $1.25B | $7.28B | 0.17 |
| 2019-03-31 | $1.20B | $7.04B | 0.17 |
| 2018-12-31 | $1.16B | $6.69B | 0.17 |
| 2018-09-30 | $1.03B | $6.29B | 0.16 |
| 2018-06-30 | $0.98B | $5.87B | 0.17 |
| 2018-03-31 | $0.92B | $5.51B | 0.17 |
| 2017-12-31 | $1.00B | $4.78B | 0.21 |
| 2017-09-30 | $0.69B | $4.96B | 0.14 |
| 2017-06-30 | $0.73B | $4.52B | 0.16 |
| 2017-03-31 | $0.68B | $4.13B | 0.17 |
| 2016-12-31 | $0.71B | $5.78B | 0.12 |
| 2016-09-30 | $0.63B | $5.54B | 0.11 |
| 2016-06-30 | $0.60B | $5.18B | 0.12 |
| 2016-03-31 | $0.56B | $4.75B | 0.12 |
| 2015-12-31 | $0.59B | $4.32B | 0.14 |
| 2015-09-30 | $0.57B | $4.12B | 0.14 |
| 2015-06-30 | $0.56B | $3.79B | 0.15 |
| 2015-03-31 | $0.54B | $3.59B | 0.15 |
| 2014-12-31 | $0.58B | $3.38B | 0.17 |
| 2014-09-30 | $0.57B | $3.08B | 0.18 |
| 2014-06-30 | $0.58B | $2.82B | 0.21 |
| 2014-03-31 | $0.54B | $3.66B | 0.15 |
| 2013-12-31 | $0.45B | $3.50B | 0.13 |
| 2013-09-30 | $0.43B | $3.26B | 0.13 |
| 2013-06-30 | $0.48B | $3.72B | 0.13 |
| 2013-03-31 | $0.46B | $3.77B | 0.12 |
| 2012-12-31 | $0.48B | $3.58B | 0.13 |
| 2012-09-30 | $0.44B | $3.29B | 0.13 |
| 2012-06-30 | $0.44B | $3.18B | 0.14 |
| 2012-03-31 | $0.41B | $2.93B | 0.14 |
| 2011-12-31 | $0.42B | $2.65B | 0.16 |
| 2011-09-30 | $0.38B | $2.37B | 0.16 |
| 2011-06-30 | $0.36B | $2.29B | 0.16 |
| 2011-03-31 | $0.34B | $2.23B | 0.15 |
| 2010-12-31 | $0.35B | $2.04B | 0.17 |
| 2010-09-30 | $0.34B | $2.01B | 0.17 |
| 2010-06-30 | $0.32B | $1.92B | 0.17 |
| 2010-03-31 | $0.25B | $1.77B | 0.14 |
| 2009-12-31 | $0.27B | $1.54B | 0.18 |
| 2009-09-30 | $0.25B | $1.39B | 0.18 |
| 2009-06-30 | $0.23B | $1.27B | 0.18 |
| 2009-03-31 | $0.21B | $1.18B | 0.18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $178.116B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
| Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
| IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
| Alcon (ALC) | Switzerland | $45.102B | 30.48 |
| DexCom (DXCM) | United States | $35.035B | 54.15 |
| IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
| Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
| STERIS (STE) | Ireland | $22.465B | 24.74 |
| Waters (WAT) | United States | $18.043B | 25.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
| Hologic (HOLX) | United States | $14.717B | 15.99 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.797B | 64.71 |
| Masimo (MASI) | United States | $8.618B | 31.79 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.358B | 0.00 |
| Teleflex (TFX) | United States | $5.103B | 8.42 |
| Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
| TransMedics (TMDX) | United States | $3.546B | 77.08 |
| PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
| Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
| Veracyte (VCYT) | United States | $1.916B | 26.89 |
| Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 126.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.29 |
| Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
| EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
| Hyperfine (HYPR) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |